Medical devices, healthcare technology and the business of care
510(k) clearance · K260075

eClinics

Ceiba Healthcare US, Inc. · Decision date Oct 7, 2026

MEDTECHLEDGER EXPLANATIONK260075

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for eClinics, a Ceiba Healthcare US, Inc. submission, on October 7, 2026, under 510(k) number K260075. The device is classified under 21 CFR 870.2300 as a Cardiac Monitor (Including Cardiotachometer And Rate Alarm), Class II, product code MSX, in the Cardiovascular panel. The summary names AirStrip ONE Web Client with ACM (K211949) as the predicate. SESE means clearance to market, not premarket approval.

The cleared indications describe software that lets trained healthcare professionals capture and display waveforms such as ECG, SpO2 and ART, discrete parameters, demographics and alarms from connected devices and electronic health record systems on centralized multi-patient views, as a diagnostic aid when staff cannot observe the source system directly. The summary lists modules including CMS Prime, CMS Telemetry, Population Management, Patient Timeline, Blood Gas, Laboratory Results, Flowsheets and Order Management. The public record does not state performance testing results or the full comparison to the predicate beyond the summary table.

The record shows conflicting dates and addresses: the decision letter is dated October 7, 2026, while the database lists a January 12, 2026 receipt date and the letter cites September 11, 2026; applicant addresses and the representative's name also differ between documents. These discrepancies are unresolved in the public information.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 7, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260075
Regulatory pathway
510(k) premarket notification
Product code
MSX
Decision code
SESE
Decision date
Oct 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Network And Communication, Physiological Monitors.

Product code
MSX
FDA device class
2

FDA decision timeline

  1. K260075 received

    Application receipt date recorded by FDA.

  2. K260075 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MSX

Product / regulatory recordCompanyPathwayDecision dateSource
Ascom Ums Srl Unipersonale510(k) clearanceSep 12, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ceiba Healthcare US, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
New York, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records